[Ip-health] MSF: Untangling the web of ARV prices (2014)

Sharonann Lynch sharonann.lynch at gmail.com
Mon Jul 28 08:08:51 PDT 2014


The latest edition of Untangling the Web of Antiretroviral Price Reductions
is now available here:


The 16th edition of Untangling the Web finds that although the price of
first- and second-line ARVs have come down thanks to increased generic
competition, third-line or salvage regimens remain exorbitantly priced, with
middle-income countries such as Armenia paying more than US$13,000 per
person per year for raltegravir, just one of the three or four drugs needed
in a third-line cocktail.

Patents remain a barrier on newer drugs and in middle-income countries, and
will need to be overcome to ensure future access to them.

Sharonann Lynch
HIV & TB Policy Advisor
Access Campaign 
Médecins Sans Frontières (MSF)
US mobile: +1 646 824 3066
sharonann.lynch at msf.org
sharonann.lynch at gmail.com

More information about the Ip-health mailing list